Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-02

Clinical Trial Update: Medication Development in Alcoholism: Investigating PPAR Agonists [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating PPAR agonists for alcoholism has completed. Results from the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PPAR agonists (investigational)

Snippet

Sponsor: The Scripps Research Institute | Conditions: Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02